Vanguard Fiduciary Trust
KYNB

Vanguard Fiduciary Trust’s Kyntra Bio KYNB Stock Holding History

Vanguard Fiduciary Trust’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Buy
24,105
+163
+0.7% +$1.14K ﹤0.01% 3603
2026
Q1 		$162K Buy
+23,942
New +$187K ﹤0.01% 3572

Other funds holding KYNB

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Fiduciary Trust's KYNB Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Kyntra Bio (KYNB) stake by 0.68% in Q2 2026, buying an estimated $1.14K and bringing the position to 24,105 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #3603.

Vanguard Fiduciary Trust first reported a position in KYNB in Q1 2026 and has held it in 2 quarters since. 27 funds tracked by Wall St. Rank hold KYNB as of Q2 2026.

  • Vanguard Fiduciary Trust held 24,105 shares of Kyntra Bio worth $182K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 163 Kyntra Bio shares in Q2 2026, an estimated $1.14K.
  • Kyntra Bio made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3603 holding.
  • Vanguard Fiduciary Trust first reported a position in Kyntra Bio in Q1 2026 and has held it in 2 quarters since.
  • 27 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.